Bedoradrine (; developmental code names KUR-1246, MN-221) is a sympathomimetic and bronchodilator medication that was developed for the treatment of preterm labor, asthma, and chronic obstructive pulmonary disease (COPD) but was never marketed. It acts as an ultra-selective long-acting ò<sub>2</sub>-adrenergic receptor agonist. The drug was intended for intravenous administration.